Table 1. Pathological diagnosis of all patients.
| Diagnosis | Case number (n = 92) |
|---|---|
| Thyroid carcinoma | 18 (19.57%) |
| Papillary carcinoma | 18 (19.57%) |
| Salivary carcinoma | 9 (9.78%) |
| Adenoid cystic carcinoma | 2 (2.17%) |
| Mucoepidermoid carcinoma | 1 (1.09%) |
| Epithelial-myoepithelial carcinoma | 1 (1.09%) |
| Nonspecific adenocarcinoma | 1 (1.09%) |
| Metastasizing pleomorphic adenoma | 1 (1.09%) |
| Ductal adenocarcinoma | 2 (2.17)% |
| Basal cell adenocarcinoma | 1 (1.09%) |
| SCC | 36 (39.13%) |
| Nasopharyngeal carcinoma | 13 (14.13%) |
| Tonsillar carcinoma | 1 (1.09%) |
| Pharyngeal carcinoma | 8 (8.70%) |
| Hypopharyngeal carcinoma | 4 (4.35%) |
| Tongue carcinoma | 4 (4.35%) |
| Esophageal carcinoma | 2 (2.17%) |
| Oropharyngeal carcinoma | 4 (4.35%) |
| Lymphoma | 29 (31.52%) |
| Mantle cell lymphoma | 1 (1.09%) |
| Follicular Lymphoma | 4 (4.35%) |
| Diffuse large B-cell lymphoma | 14 (15.22%) |
| Peripheral T-cell lymphoma | 1 (1.09%) |
| Nodular sclerosis Hodgkin lymphoma | 3 (3.26%) |
| Mixed cellularity Hodgkin lymphoma | 2 (2.17%) |
| Lymphocyte-rich Hodgkin lymphoma | 1 (1.09%) |
| Lymphocyte depletion Hodgkin lymphoma | 1 (1.09%) |
| Extranodal nasal-type natural killer/T-cell lymphoma | 1 (1.09%) |
| Peripheral T-cell lymphoma | 1 (1.09%) |
TC is the abbreviation of thyroid carcinoma. SC is the abbreviation of salivary carcinoma. SCC is the abbreviation of squamous cell carcinoma.